|April 2, 2014|
|06:22 EDT||CTSH||Cognizant upgraded to Buy from Neutral at UBS|
UBS upgraded Cognizant and said it is well positioned for the current demand environment as IT budgets are focused on cost optimization and believes discretionary project spending will be solid. The analyst expect Cognizant to announce a more formal capital return policy this year and views valuation as attractive. Price target raised to $58 from $50.
News For CTSH From The Last 14 Days
|July 6, 2015|
|10:01 EDT||CTSH||On The Fly: Analyst Upgrade Summary|
Today's noteworthy upgrades include: 58.com (WUBA) upgraded to Buy from Hold at Summit Research... Altria Group (MO) upgraded to Buy from Outperform at CLSA... Ares Commercial (ACRE) upgraded to Outperform from Market Perform at FBR Capital... BAE Systems (BAESY) upgraded to Overweight from Equal Weight at Morgan Stanley... BGC Partners (BGCP) upgraded to Strong Buy from Outperform at Raymond James... Cognizant (CTSH) upgraded to Buy on valuation at CLSA... Edwards Lifesciences (EW) upgraded to Overweight from Equal Weight at Morgan Stanley... Guess (GES) upgraded to Neutral from Underweight at Piper Jaffray... MarkWest Energy (MWE) upgraded to Overweight from Equal Weight at Barclays... Palo Alto (PANW) upgraded to Outperform following checks at Cowen... The Medicines Co. (MDCO) upgraded to Buy from Neutral at Mizuho... TripAdvisor (TRIP) upgraded to Equal Weight from Underweight at Barclays... Union Pacific (UNP) upgraded to Outperform at Cowen... United Continental (UAL) upgraded to Buy from Fair Value at CRT Capital... eHealth (EHTH) upgraded on Medicare outlook, risk/reward at RBC Capital.
|08:18 EDT||CTSH||Cognizant upgraded to Buy on valuation at CLSA|
As previously reported, CLSA upgraded Cognizant to Buy from Outperform with a $75 price target. The firm would use weakness as a buying opportunity and said the loss of the Health Net (HNT) contract was very sub-par margin revenue.
|06:17 EDT||CTSH, CTSH||Cognizant upgraded to Buy from Outperform at CLSA|
|July 2, 2015|
|12:00 EDT||CTSH||Cognizant ability to offset Health Net loss a positive, says Wells Fargo|
Wells Fargo notes that despite the loss of $100M in revenue in the second half of 2015 from the Health Net (HNT) master services agreement being put on hold during the Centene (CNC) merger review process, Cognizant (CTSH) reaffirmed its outlook today for 2015. Wells views the company's ability to offset the contract loss as a positive and says it remains comfortable with an Outperform rating on the stock.
|09:36 EDT||CTSH||Cognizant backs FY15 EPS view of at least $2.93, consensus $2.97|
Subscribe for More Information
|09:33 EDT||CTSH||Cognizant reaffirms 2015 view after Health Net agrees to be bought by Centene |
Subscribe for More Information
|June 24, 2015|
|05:35 EDT||CTSH||Cognizant announces strategic relationship with Escorts Limited|
Cognizant announced a strategic relationship with Escorts Limited, one of India's engineering conglomerates, to modernize Escorts' technology landscape and help achieve the company's vision of digitally transforming its businesses to deliver innovative products, provide superior customer experience, and drive growth. This multi-year, multi-million dollar engagement spans all of Escort's businesses, including agri-machinery, material handling and construction equipment, railway equipment and auto components. Cognizant will enable Escorts to improve control and collaboration across its value chain by mobile-enabling its workforce and integrating multiple systems used by vendors, sales partners, and customers. This will help Escorts continuously improve product quality and offer a broad range of customized, configurable, and value-added products and services, strengthening existing customer relationships and building new ones.
|June 22, 2015|
|09:01 EDT||CTSH||Cognizant management to meet with JPMorgan|
Meetings to be held in Berwyn/Princeton/Trenton on June 25 hosted by JPMorgan.